{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:59:28Z","timestamp":1771016368593,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.tmaid.2007.10.002","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T11:45:55Z","timestamp":1196941555000},"page":"182-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Meningococcal disease: Risk for international travellers and vaccine strategies"],"prefix":"10.1016","volume":"6","author":[{"given":"Annelies","family":"Wilder-Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tmaid.2007.10.002_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/ije\/16.1.91","article-title":"Control of epidemic group A meningococcal meningitis in Nepal","volume":"16","author":"Cochi","year":"1987","journal-title":"Int J Epidemiol"},{"issue":"7483","key":"10.1016\/j.tmaid.2007.10.002_bib2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/bmj.330.7483.133","article-title":"Hajj: journey of a lifetime","volume":"330","author":"Gatrad","year":"2005","journal-title":"BMJ"},{"issue":"7360","key":"10.1016\/j.tmaid.2007.10.002_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.325.7360.365","article-title":"Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study","volume":"325","author":"Wilder-Smith","year":"2002","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.tmaid.2007.10.002_bib4","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/QCO.0b013e3282a64700","article-title":"Meningococcal vaccine in travelers","volume":"20","author":"Wilder-Smith","year":"2007","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2007.10.002_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1708-8305.1994.tb00548.x","article-title":"Meningococcal disease in travelers: vaccination recommendations","volume":"1","author":"Koch","year":"1994","journal-title":"J Travel Med"},{"issue":"2","key":"10.1016\/j.tmaid.2007.10.002_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0924-8579(02)00284-4","article-title":"Meningococcal disease and travel","volume":"21","author":"Wilder-Smith","year":"2003","journal-title":"Int J Antimicrob Agents"},{"issue":"18","key":"10.1016\/j.tmaid.2007.10.002_bib7","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"issue":"12 Suppl","key":"10.1016\/j.tmaid.2007.10.002_bib8","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1097\/01.inf.0000147642.85129.05","article-title":"Global epidemiology of meningococcal disease and vaccine efficacy","volume":"23","author":"Pollard","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.tmaid.2007.10.002_bib9","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1086\/377739","article-title":"Neisseria meningitidis strains isolated from invasive infections in France (1999\u20132002): phenotypes and antibiotic susceptibility patterns","volume":"37","author":"Antignac","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.tmaid.2007.10.002_bib10","first-page":"77","article-title":"The risk of epidemic meningitis in Africa: a cause for concern","volume":"82","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"issue":"12","key":"10.1016\/j.tmaid.2007.10.002_bib11","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1046\/j.1360-2276.2003.01126.x","article-title":"Outbreaks of serogroup X meningococcal meningitis in Niger 1995\u20132000","volume":"8","author":"Djibo","year":"2003","journal-title":"Trop Med Int Health"},{"issue":"6","key":"10.1016\/j.tmaid.2007.10.002_bib12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1086\/367858","article-title":"Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers","volume":"36","author":"Wilder-Smith","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.tmaid.2007.10.002_bib13","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3201\/eid0906.020725","article-title":"Absence of Neisseria meningitidis W-135 electrophoretic Type 37 during the Hajj, 2002","volume":"9","author":"Wilder-Smith","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.tmaid.2007.10.002_bib14","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/515346","article-title":"Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination","volume":"178","author":"Granoff","year":"1998","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.tmaid.2007.10.002_bib15","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1016\/j.vaccine.2006.03.034","article-title":"A review of vaccine research and development: meningococcal disease","volume":"24","author":"Girard","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.tmaid.2007.10.002_bib16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2310\/7060.2002.23861","article-title":"Vaccination against meningococal disease: which vaccine to use?","volume":"9","author":"Broker","year":"2002","journal-title":"J Travel Med"},{"issue":"14","key":"10.1016\/j.tmaid.2007.10.002_bib17","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1016\/j.vaccine.2005.12.018","article-title":"Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine","volume":"24","author":"El Bashir","year":"2006","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.tmaid.2007.10.002_bib18","first-page":"2049","article-title":"Prevention of meningococcal disease","volume":"72","author":"Kimmel","year":"2005","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.tmaid.2007.10.002_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.inf.0000148928.10057.86","article-title":"Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children","volume":"24","author":"Pichichero","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.tmaid.2007.10.002_bib20","unstructured":"Update: Guillain\u2013Barre syndrome among recipients of Menactra meningococcal conjugate vaccine, United States. June 2005\u2013September 2006. MMWR Morb Mortal Wkly Rep 2006;55(41):1120\u20134."},{"issue":"1","key":"10.1016\/j.tmaid.2007.10.002_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2310\/7060.2002.22452","article-title":"Epidemic meningococcal disease and travel","volume":"9","author":"Pollard","year":"2002","journal-title":"J Travel Med"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893907001317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893907001317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:56:39Z","timestamp":1761486999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893907001317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1477893907001317"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2007.10.002","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meningococcal disease: Risk for international travellers and vaccine strategies","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2007.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}